10 min listen
Johnson & Johnson (JNJ) Earnings Prove The Free Cash Is Flowing
FromSchwab Network
ratings:
Length:
6 minutes
Released:
Apr 19, 2023
Format:
Podcast episode
Description
Healthy free cash flow has enabled Johnson & Johnson (JNJ) to increase its dividend over the past half century, notes Lee Bohl. He and Damien Conover discuss takeaways from JNJ earnings. JNJ's 1Q worldwide pharmaceutical sales came in at $13.41B and its 1Q revenue came in at $24.75B versus an estimated $23.57B. They also go over other stocks to keep on your radar. Tune in to find out more about the stock market today.
Released:
Apr 19, 2023
Format:
Podcast episode
Titles in the series (100)
What is a K -Shaped Recovery? by Schwab Network